Moreover, the proposed triad of gastric localization, primary tumor size greater than 10 cm, and low SUVmax may have a clinical utility in identifying PDGFRA-mutant GISTs, for better tailoring both molecular assessment and clinical decision-making. Here, PDGFRA is linked to neoplasm.